Abstract Renal vein thrombosis and the congenital nephrotic syndrome have been associated with nephrotic-range proteinuria/nephrotic syndrome and hypertension in the newborn period. We describe a newborn with severe hypertension and proteinuria secondary to unilateral renal artery stenosis. Proteinuria completely disappeared with blood pressure control (with sodium nitroprusside and an angiotensin-converting enzyme inhibitor). Although renin was not measured, we speculate that proteinuria might have been induced by a high renin state, and was controlled by the angiotensin-converting enzyme inhibitor.
Introduction
The simultaneous occurrence of hypertension and proteinuria/nephrotic syndrome in a newborn raises the differential diagnosis of a congenital nephrotic syndrome or a renal vein thrombosis (RVT). Renal artery stenosis (RAS) has been associated with proteinuria or even nephrotic syndrome, mainly in adult patients. Recently, Lang and Gowrishankar [1] described a young child with RAS and nephrotic syndrome. We wish to further expand the rare clinical association of RAS, hypertension, and nephrotic-range proteinuria in a newborn baby.
Case report
The female patient was delivered vaginally at 42 weeks of gestation, after an uneventful pregnancy. The 24-year-old mother had no diabetes and was on no medications. The birth weight was 3,485 g (50th percentile) and length 50 cm (10th-50th percentile). Apgar scores were 7, 9, and 9 at 1, 5, and 10 min, respectively. Initial blood pressure values (10 h after birth) were high at 85/ 50 mmHg [2] . Because of mild tachypnea, the child was admitted to a neonatal division and closely monitored. On day 3 of life, blood pressure was 100-105/80 mmHg, and she developed nephrotic-range proteinuria and microscopic hematuria. Laboratory results included plasma creatinine 76 mmol/l, blood urea nitrogen 3.9 mmol/l, and albumin 33 g/l. The urinary protein/creatinine ratio was 5,807 g/mol (66 g/l). Urinalysis revealed 0-1 white blood cells/ high-power field (HPF), 10-15 red blood cells/HPF, and no casts. Renal ultrasonography showed two normal-sized kidneys with normal arterial and venous blood flow and no signs of venous thrombosis. The infant's condition deteriorated and she was transferred to our hospital. On admission (day 5 of life), she was hypertensive (115/86 mmHg) and in heart failure. There was an enlarged liver and generalized edema. Laboratory investigations confirmed the proteinuria (1,176 g/mol), with mild hypoalbuminemia (30 g/l), no electrolyte abnormalities, creatinine 96 mmol/l, serum glutamic oxaloacetic transaminase 66 U/l, and serum glutamic pyruvic transaminase 110 U/l. Echocardiography showed a slight hypertrophied and dilated left ventricle, with an ejection fraction of 37%. There was a slight mitral and aortic insufficiency. Because of failure of captopril, furosemide, and hydralazine to adequately control the blood pressure, sodium nitroprusside was added. The blood pressure response was immediate (Fig. 1) . Oral labetalol was added on day 9 of life, in order to wean the infant off sodium nitroprusside. Two weeks later, the infant's blood pressure was controlled with oral labetalol (16 mg three times a day) and captopril (0.1 mg twice daily). Proteinuria decreased and then disappeared as soon as the blood pressure normalized (Fig. 1) . At discharge, there was no proteinuria and no hematuria. On day 8 of life, 3 days after a single dose of furosemide, the patient also presented with hyponatremia (128 mmol/l) secondary to renal salt wasting (urine sodium 92 mmol/l). Hyponatremia resolved spontaneously, without sodium supplementation. Duplex Doppler sonography on day 9 of life showed a small right kidney with a decreased arterial signal, but normal venous flow; the left kidney was normal. Magnetic resonance angiography revealed a stenotic/ hypoplastic right renal artery and a normal left renal artery (Fig. 2) .
Renal scan (Mag3) performed on day 10 of life showed no activity on the right side and a compensatory hyperactivity on the left side. At discharge (day 18 of life), the patient was normotensive, with a creatinine of 56 mmol/l and sodium of 135 mmol/l. Eight months later, she is on enalapril 0.6 mg twice daily, her blood pressure is normal (90/50 mmHg), and she has no proteinuria or hematuria. Follow-up renal ultrasonography, a year later, shows a small atrophic right kidney (<5th percentile) with a hypertrophied left kidney (95th percentile). Echocardiography performed 3 months after discharge is also normal, with complete regression of the left ventricular failure. A repeat renal scan confirmed the total absence of perfusion of the right kidney, and showed a well-functioning left kidney, with some mild irregularities and a heterogeneous distribution of the nuclear tracer.
Discussion
The differential diagnosis of severe hypertension in a newborn baby includes acquired or congenital renal vascular diseases (RAS, renal artery hypo(dys)plasia, thromboembolic events), renal parenchymal/glomerular disorders, obstructive uropathies, coarctation of the aorta, or drug-induced hypertension [3] . Amongst those causes, only RVT, congenital nephrotic syndrome (of any etiology), or RAS have been associated with nephrotic-range proteinuria or even frank nephrotic syndrome. Although RVT can rarely induce a nephrotic syndrome [4, 5] , it is mostly a direct consequence of hemoconcentration and chronic urinary loss of anti-thrombin III secondary to a primary long-standing nephrotic syndrome. RVT was excluded in our patient (no thrombopenia, no macroscopic hematuria, normal renal venous blood flow, no enlarged hyperechogenic kidneys). RAS has also been associated with mild-to-severe proteinuria [6] or even nephrotic syndrome [1, 7] . The occurrence of proteinuria after renal artery occlusion is thought to be secondary either to the high renin state and tissue ischemia in the occluded kidney or to an excessive blood flow in the contralateral healthy kidney, or both [6] . Focal and segmental glomerulosclerosis of the healthy contralateral kidney has also been described in patients with longstanding RAS [8] . Proteinuria in that case is secondary to chronic hyperfiltration of the remaining nephrons.
Although plasma renin activity was not measured, we suggest that the nephrotic-range proteinuria and the hypertension in our patient were induced or exacerbated by the exaggerated renin production in the ischemic right kidney. Proteinuria decreased and then disappeared with the administration of an angiotensin-converting enzyme inhibitor. Renin increases angiotensin II, which has been shown to modulate glomerular capillary permselectivity in experimental animals [9] . Our patient also presented with transient renal sodium loss. Renal salt wasting has also been reported in malignant hypertension [10] . The mechanism of sodium loss is not completely understood. In animal experiments, an acute increase in the arterial perfusion pressure in the isolated kidney of the dog led to an increase in urine flow and sodium excretion, whereas the glomerular filtration rate and renal blood flow were unchanged [11] . The persistence of hypertension, more than a year after the initial event, might be explained by persistent renin secretion in the ipsilateral kidney, or by the contralateral kidney, which showed numerous irregularities on renal scan, corresponding probably to renal scars.
In summary, we describe a newborn baby with hypertension and nephrotic-range proteinuria, secondary to RAS, which responded well to an angiotensin-converting enzyme inhibitor. We speculate that an excessively stimulated renin-angiotensin-aldosterone system might have been responsible for the heavy proteinuria, through altered permeability of the glomerular capillaries. RVT, congenital nephrotic syndrome, and likewise RAS should be ruled out in a newborn presenting with severe hypertension and proteinuria.
